Lake Mary, Florida (PRWEB) February 11, 2015
Axium Healthcare Pharmacy announced today that it has been selected as a specialty pharmacy network provider for GlaxoSmithKline’s (GSK’s) lupus drug BENLYSTA® (belimumab). BENLYSTA® is indicated for the treatment of adult patients with active, autoantibody-positive, systemic lupus erythematosus (SLE) who are receiving other standard therapies.
BENLYSTA® is a biologic therapy that is delivered through an intravenous (IV) infusion. It works by reducing certain cells in a person’s immune system that can make lupus active. Full prescribing information for BENLYSTA® is available at http://www.benlysta.com.
As a specialty network provider of BENLYSTA®, Axium provides patients and prescribers with the following benefits:
---24x7x365 clinical support including patient care coordinators, registered nurses, licensed pharmacists and insurance specialists.
---Dedicated physician account managers.
---Patient copay assistance and dedicated PAP sourcing programs.
---Patient training and education about treatment programs and medication.
---Side effect management.
---Patient compliance and adherence management.
---Free, quick and confidential medication delivery for patients.
---Anytime-anywhere patient therapy management through Axium’s OnePlace treatment management portal.
---Axium is e-script ready.
About Axium Healthcare Pharmacy
Founded in 2000, Axium Healthcare Pharmacy, Inc. is a nationwide provider of specialty pharmacy services. A wholly-owned subsidiary of The Kroger Company, Axium provides drug therapies and patient support services to treat chronic, genetic, and other complex conditions such as Hepatitis C, Multiple Sclerosis, Cancer, Rheumatoid Arthritis, and a number of others.
For more information, contact Axium Healthcare Pharmacy at 888.315.3395 or visit http://www.axiumhealthcare.com.